Lorena Munoz
Overview
Explore the profile of Lorena Munoz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Otaola-Arca H, Mejias O, Bravo J, Pinochet R, Bernier P, Munoz L, et al.
Ann Med Surg (Lond)
. 2023 May;
85(5):1480-1485.
PMID: 37229062
Methods: Comparative retrospective cohort study including patients with non-metastatic prostate cancer treated with RARP by four expert surgeons at a robotic referral centre between January 2020 and December 2021. A...
2.
Murray N, Orrego S, Lopez M, Munoz L, Minzer S
Ecancermedicalscience
. 2020 Jan;
13:972.
PMID: 31921343
Therapy-related acute lymphoblastic leukaemia (t-ALL) is a poorly defined entity and is not featured in the World Health Organization classification as a distinct clinical entity from acute lymphoblastic leukaemia (ALL),...
3.
Murray N, Fuentealba C, Reyes E, Lopez M, Salazar A, Minzer S, et al.
Asian Pac J Cancer Prev
. 2019 Nov;
20(11):3385-3389.
PMID: 31759363
Introduction: An elevated serum PSA is the only biomarker routinely used in screening for prostate cancer to indicate a prostate biopsy. However, it is not specific for prostate cancer and...
4.
Murray N, Minzer S, Lopez M, Munoz L
Hematol Transfus Cell Ther
. 2019 Nov;
42(3):283-286.
PMID: 31672588
No abstract available.
5.
Murray N, Aedo S, Villalon R, Lopez M, Minzer S, Munoz L, et al.
Ecancermedicalscience
. 2019 Jul;
13:935.
PMID: 31281432
Introduction: 25% of Stage III colon cancer patients relapse within 5 years due to minimal residual disease (MRD) not eliminated by surgery and chemotherapy. We hypothesise that sub-types of MRD,...
6.
Murray N, Munoz L, Minzer S, Lopez M
Case Rep Hematol
. 2018 Sep;
2018:2615838.
PMID: 30254772
Nonvalvular atrial fibrillation (AF) is a common age-related arrthymia and a leading cause of stroke in the elderly; with an aging hemophilia population, the number of patients developing AF is...
7.
Castillo C, Munoz L, Carrillo I, Liempi A, Medina L, Galanti N, et al.
Placenta
. 2017 Dec;
60:40-46.
PMID: 29208238
Background: Congenital Chagas disease is caused by the protozoan parasite Trypanosoma cruzi that must cross the placental barrier during transmission. The trophoblast constitutes the first tissue in contact with the...
8.
Jaramillo J, Rendon M, Munoz L, Weis M, Trommsdorff G
Front Psychol
. 2017 Jun;
8:923.
PMID: 28634460
Self-regulation is a complex multidimensional construct which has been approached mainly in Western cultural contexts. The present contribution examines the importance of considering the culture-sensitive nature of self-regulation by reviewing...
9.
Castillo C, Munoz L, Carrillo I, Liempi A, Gallardo C, Galanti N, et al.
Am J Reprod Immunol
. 2017 Mar;
78(1).
PMID: 28328108
Problem: Trypanosoma cruzi and Toxoplasma gondii present, respectively, low and high congenital transmission rates. The placenta as an immune regulatory organ expresses TLRs, leading to the secretion of cytokines. Both...
10.
Droguett D, Carrillo I, Castillo C, Gomez F, Negrete M, Liempi A, et al.
Exp Parasitol
. 2016 Dec;
173:9-17.
PMID: 27939813
Congenital transmission of Trypanosoma cruzi (T. cruzi) is partially responsible for the progressive globalization of Chagas disease. During congenital transmission the parasite must cross the placental barrier where the trophoblast,...